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Abstract 
 Metabolomics incorporates the study of metabolites that are produced and released 
through physiological processes at both the systemic and cellular level. Biological compounds 
at the metabolite level are of paramount interest in the sport and exercise sciences, although 
research in this field has rarely been referred to with the global ‘omics terminology. Commonly 
studied metabolites in exercise science are notably within cellular pathways for ATP 
production such as glycolysis (e.g. pyruvate and lactate), β-oxidation of free fatty acids (e.g. 
palmitate) and ketone bodies (e.g. β-hydroxybutyrate). Non-targeted metabolomic 
technologies are able to simultaneously analyse the large numbers of metabolites present in 
human biological samples such as plasma, urine and saliva. These analytical technologies 
predominately employ nuclear magnetic resonance spectroscopy and chromatography coupled 
to mass spectrometry. Performing experiments based on non-targeted methods allows for 
systemic metabolite changes to be analysed and compared to a particular physiological state 
(e.g. pre/post-exercise) and provides an opportunity to prospect for metabolite signatures that 
offer beneficial information for translation into an exercise science context, for both elite 
performance and public health monitoring. This narrative review provides an introduction to 
non-targeted metabolomic technologies and discusses current and potential applications in 
sport and exercise science.  
  
1. Introduction 
The study of human metabolism in response to acute bouts of exercise and chronic 
exercise training traditionally involves the measurement of selected metabolites, transcription 
factors and proteins (Egan, Hawley, & Zierath, 2016). This has provided mechanistic insights 
into the phenotypic changes observed with exercise training and has enabled the development 
of targeted training and nutritional strategies to maximise adaptations for health and 
performance, for example, the timing of carbohydrate intake to maximise activation of key cell 
signalling proteins (Impey et al., 2016) and the application of short-term exercise training to 
increase insulin-mediated glucose disposal in obese people with type 2 diabetes (O’Gorman et 
al., 2006). Advanced investigatory techniques such as metabolomics offer the potential to 
develop the existing knowledge of metabolites and discover novel markers that can provide 
important information to exercise scientists.  
This narrative review is intended to provide an overview of what metabolomics offers 
as an experimental method and give a brief explanation of the current analytical and 
bioinformatic techniques employed for non-targeted metabolomics. Examples of where these 
techniques have been initially employed into exercise-based experiments are illustrated, and 
potential future directions that metabolomics methodologies may take in providing additive 
information into the sport and exercise sciences are discussed. 
 
2. What is metabolomics? 
Metabolites are defined as “low molecular weight organic and inorganic chemicals 
which are the reactants, intermediates or products of enzyme-mediated biochemical reactions” 
(Dunn, Broadhurst, Atherton, Goodacre, & Griffin, 2011, p. 387), with the term ‘metabolome’ 
used to describe the complete array of these metabolites found secreted by a living 
cell/organism (Nicholson, & Wilson, 2003). The study of the metabolome, metabonomics, was 
  
first described as “the quantitative measurement of the dynamic multiparametric metabolic 
response of living systems to pathophysiological stimuli or genetic modification” (Nicholson, 
Lindon, & Holmes, 1999, p. 1181). In addition to metabonomics where measurements are made 
of metabolites that are present from metabolic responses in multicellular systems, for example 
metabolites released by commensal and symbiotic organisms, metabolomics involves 
measurements of metabolites directly connected to genetic, metabolic and protein-driven 
processes (Nicholson, & Wilson, 2003). These metabolites may be present in tissues, bio fluids 
(e.g. plasma/serum and urine) and/or in volatilised form in exhaled breath gases. The premise 
of metabolomics is that small molecule metabolites measured in a biological medium report on 
the physiological state, or changes in response to an intervention, occurring within that 
organism.  
Like other methodologies carrying the ‘omics tag, for example genomics and 
proteomics, metabolomics can employ both targeted and non-targeted strategies. Targeted 
analyses can be applied to identify metabolites related to specific biological 
processes/pathways that modulate a biological function of interest (Griffiths et al., 2010). 
Targeted assays have been developed for commercial distribution, for example the 
AbsoluteIDQ test kit (Biocrates Life Sciences, Innsbruck, Austria) for the measurement of 
amino acids, glycerophospholipids and acylcarnitine molecules known to be involved in cell 
energy metabolism. In contrast, non-targeted metabolomics (also known as unbiased, global or 
discovery metabolomics) employs a wide-scope analytical collection (Fuhrer, & Zamboni, 
2015) and measurement technique whereby all detectable metabolites are (semi-)quantitated, 
collated and prospected for (bio)markers that are indicative of predefined conditions (e.g. 
metabolites that discriminate between diagnosis of diseased and healthy individuals). These 
assigned biomarkers may reflect causative and/or associative relationships with a physiological 
  
state of interest, allowing them to aid in the examination of current health or be applied for 
diagnostic, prognostic and therapeutic purposes.  
Through recent technological and methodological advances in the field of 
metabolomics, it has been possible to characterise, quantitate and identify an increasing number 
of analytes. Development and publication of open-source searchable metabolite databases have 
been possible through the increased availability of metabolite properties (e.g. molecular mass 
and analytical assay characteristics – discussed in more detail later). Perhaps the most relevant 
to human investigations is the Human Metabolome Database (HMDB) which was first 
published in 2007 (Wishart et al., 2007) and has since been updated, with the latest edition 
released in 2013 (Wishart et al., 2013). HMDB describes over 40,000 metabolites and each is 
represented with a ‘metabocard’ that details associated chemical, biochemical, clinical and 
enzymatic data, with links to website resources of additional information (The Human 
Metabolome Database, 2016). Databases such as HMDB have greatly assisted in the 
identification and understanding of physiological relevance for metabolites that have been 
discovered through non-targeted strategies. 
 
3. Commonly employed analytical techniques 
 Nuclear magnetic resonance spectroscopy (NMR) is an analytical technique often used 
in organic chemistry to confirm the structure of a synthesised compound. The information 
provided by NMR can also be applied to biological samples and allows for structural 
identification of the molecules present.  
NMR uses a high-powered magnet to induce a magnetic field that causes some atomic 
nuclei to spin. For 1H NMR, commonly employed in metabolomics studies (Want et al., 2010), 
the induced magnetic field causes the protons to align in an orientation corresponding to low 
or high energy; these are known as α and β states, respectively. The sample is then subjected 
  
to applied radio waves which cause those nuclei in the α state to shift to the β state. Once the 
applied energy is removed, the nuclei return to their original energy state and an alteration in 
magnetic field, known as resonance, can be measured and interpreted as peaks on NMR spectra. 
The magnetic field expressed on the nuclei is influenced by both the externally applied field 
and the magnetic effect of localised nuclei/electrons, causing changes in the resonance 
frequency in comparison to that seen from a singular atom. These changes in resonance are 
compared to a standard, which is defined as zero, and the difference observed is known as the 
chemical shift. These chemical shifts are characteristic for certain molecular structures and 
therefore can be used to identify molecules, or parts of molecular structure, present in the 
sample which aids in identification of the measured metabolites. As not all isotopes exhibit a 
magnetic spin (for example, 12C is not magnetic, where 13C is), it means that not all molecules 
can be studied using NMR and therefore the technique is limited in its application to metabolite 
measurement on a global scale. 
 Mass spectrometry (MS) is commonly employed for the analysis of metabolites in a 
global, non-targeted way (Dunn et al., 2011). MS offers highly sensitive, specific, accurate, 
rapid and robust analytical assays that are perfectly adapted to measure multiple metabolites 
using singular preparation and analysis methods (Dunn et al., 2011). As modern mass 
spectrometers are able to utilise large analytical mass scan windows (often in excess of 1000 
Da), there is an innate ability to measure all detectable small molecule metabolites present 
within a sample. Rapid and wide-scan capabilities allow for large databases of study-specific 
metabolites to be produced and subsequently implemented in multivariate statistical models to 
discover those which are highly associated with the target state. 
One of the most difficult aspects of non-targeted metabolomics is the confident 
identification of a measured metabolite of interest (Dunn, Broadhurst, Atherton et al., 2011). 
The application of modern high-resolution mass analysers, such as time-of-flight and the 
  
orbitrap, has improved analyte identification with the ability to measure mass-to-charge ratios 
(m/z) with an error of less than 10 parts per million (<0.001%). Highly accurate measured 
masses can then be compared to open-source databases and consequently given a tentative 
identification for a molecule’s name/structure. High-resolution measurements provide 
information that greatly reduces the complexity and, therefore, increases the success of positive 
identification over the use of nominal mass (i.e. to the nearest Da) systems such as the 
quadrupole and ion-trap mass analysers.  
In addition to the m/z measured of the intact molecule, a collision energy can be applied 
causing the metabolite to fragment. The fragments formed and their ratios to the precursor 
molecule are reproducible providing the collision energy value is maintained across analytical 
runs. Known as tandem MS or MS/MS, this process of fragmentation allows for additional 
validation of metabolite identification through comparison of mass spectra with and without a 
collision energy applied. MS/MS is particularly useful where two or more isomeric molecules, 
i.e. possess the same empirical formula and therefore identical m/z value, display alternative 
fragmentation properties and therefore offers the capability of identifying a particular 
metabolite isomer. 
 Metabolite identification can be further enhanced through the coupling of 
chromatographic techniques such as liquid and gas chromatography (LC, GC) to MS (Creek et 
al., 2011). LC is applied to non-volatile metabolites and is often used for blood and urine based 
analyses, whilst GC requires the metabolite to enter the analytical system in the gas phase and 
therefore is most suitable for volatile metabolites, liquid headspace and breath gas analyses.  
Chromatography uses the affinity of molecules to a stationary phase for deconvolution 
of complicated matrices that contain many hundreds of metabolites (e.g. plasma/serum). As the 
metabolites pass along the chromatographic column their varying affinities to the stationary 
phase cause them to exhibit different times between entry and exit of the analytical column. 
  
These properties cause metabolites to be separated and introduced into the mass spectrometer 
at intervals, thereby reducing the complexity of each MS scan. Decreased analytical 
complexity, through separation of molecules, improves metabolite identification through the 
reproducibility of metabolite retention times when chromatographic conditions are maintained 
across analytical runs. GC also offers the use of Kovát’s retention index (Kováts, 1958), where 
a series of homologous alkanes provide comparative retention time data across different 
chromatographic conditions. These retention indices can be compared to published values (e.g. 
the NIST mass spectral library) for more confident identification of analytes.  
The combination of chromatography with MS allows for the analysis of known standard 
reference compounds and comparison of retention time, mass spectra and MS/MS spectra for 
definitive identification of metabolites. Although GC-MS and LC-MS are not currently 
employed for exercise and sport-based situations in training or performance contexts, they are 
commonly used in anti-doping strategies for testing of athlete samples for banned substances 
(Thevis, Kuuranne, Walpurgis, Geyer, & Schanzer, 2016).  
A basic workflow for a non-targeted metabolomic experiment can be seen in Figure 1, 
and the advantages and limitations of using NMR and MS as technologies for non-targeted 
metabolomics studies are detailed in Table 1. 
 
4. Commonly used bioinformatics for metabolomics 
Non-targeted experiments produce large numbers of measured variables and therefore 
the way in which data are processed is an important factor for isolating meaningful associations 
with a variable/state of interest. For investigating changes in metabolites between predefined 
states, principal components analysis (PCA) and [orthogonal] partial least squares-discriminant 
analysis ([O]PLS-DA) are commonly used statistical techniques. PCA and OPLS-DA allow 
visualisation of multi-dimensional relationships of measured variables (i.e. metabolites) to 
  
predefined states (e.g. healthy and diseased) (Worley & Powers, 2013). PCA is an unsupervised 
method which projects data points onto a plot to visualise their distribution dependent on 
metabolite correlations that show the largest deviations across the dataset. PCA can be utilised 
to examine trends within a dataset without the force fitting for differences between pre-defined 
groups. This is particularly important for the analysis of quality control (QC) samples injected 
at regular intervals throughout experimental periods, with a tight cluster of these samples 
present within the PCA plot indicative of good analytical reproducibility and, therefore, low 
study bias (Figure 2). Supervised, or discriminant, analyses are methods that isolate the 
metabolites with the largest variation between predefined groups, allowing individual 
metabolites to be isolated by sensitivity and selectivity of group prediction. Methods such as 
OPLS-DA allow a refocus of analysis to understand differences related specifically to the 
experimental question, e.g. pre- versus post-exercise state, reducing the impact of systemic 
variation that may influence PCA models (Wiklund et al., 2008). In addition, OPLS-DA models 
produce a corresponding S-plot which visualises the covariance and correlation between 
metabolites and the computed model (Wiklund et al., 2008), indicating potential biomarkers to 
be isolated to be taken forward for more targeted statistical testing (Figure 2). As these methods 
use large numbers of variables to compute models, pre-treatment of the data can prove 
influential on corresponding results. Techniques such as normalisation, missing value 
imputation, transformation and scaling must be used with care to ensure the validity of results 
obtained (Di Guida et al., 2016). Metabolite relationships with continuous variables, for 
example VO2max, are predominantly investigated by correlation analyses for single metabolites, 
or multiple linear regression for combining several metabolites.  
 
  
  
5. Current investigations in sport and exercise science 
 In the context of sport and exercise science, NMR and MS-based techniques have 
allowed researchers to explore human metabolism in response to acute and chronic exercise. 
This includes the use of NMR to measure substrate use (Gonzalez et al., 2015) and metabolic 
perturbations during exercise (Jones, Wilkerson, & Fulford, 2008). MS has also been 
extensively used in combination with stable isotope tracers to assess substrate use during 
exercise (e.g. O’Hara et al., 2012) and to assess the total energy expenditure of elite athletes 
(Fudge et al., 2006). Alternatively, non-targeted metabolomics experiments are a contemporary 
adaptation to research methodologies in sport and exercise science. These unbiased ‘discovery’ 
methods have shown utility in medical research with prospective novel biomarkers identified 
in lung cancer (Mathé et al., 2014) and cardiovascular disease (Wang et al., 2011), amongst 
other conditions. The use of non-targeted metabolomics in sport and exercise science represents 
an exciting prospect as a method for identifying novel biomarkers relevant to the health and 
performance effects of sport and exercise interventions. To date, experiments performed using 
non-targeted metabolomics in this field have predominantly observed fluctuations in 
metabolites related to energy production pathways, and have been measured in blood, urine 
and saliva samples. These experiments are reviewed below, with potential future directions 
also identified.  
 The principal understanding sought of the exercise metabolome, and the most prevalent 
in the current literature, is how the metabolite abundances change from rest after an exercise 
intervention. Understanding these changes and identifying novel biomarkers may provide 
further insight into the metabolic regulation of adaptation for the future refinement of exercise 
programs for sporting performance. Exercise programs may also be refined for optimal health 
benefits based on this rationale and it also allows for further investigation of the interaction 
  
between nutritional interventions, metabolic perturbations and chronic adaptations to exercise 
training.  
The first investigation into multivariate modelling of exercise metabolome profiling 
was performed by Pohjanen and colleagues (2007) where 402 serum metabolites were used for 
prediction of the pre- or post-exercise state. Discriminant analyses were used to highlight 34 
metabolites with significant changes between groups (paired t test p < 8.2x10-5) and showed 
major contributions from increased glycerol and decreased asparagine after a multiple-bout, 
sub-maximal exercise session. Although this proof of concept study did not investigate the 
mechanistic effects of these changes, the study highlighted the potential for non-targeted 
metabolomics to identify changes in metabolites in response to an exercise bout that are beyond 
the traditional measures used within the sport and exercise sciences.  
Further investigations have noted changes in metabolites related to lipid and glucose 
metabolism at a range of exercise durations and intensities. An intensified training period in 
endurance athletes which involved a repeated running protocol of 2.5 hrs/day (for 3 days) at 
70% VO2max, induced significant elevations in metabolites related to lipid metabolism 
(Nieman, Shanely, Gillitt, Pappan, & Lila, 2013). Furthermore, the sustained elevation of these 
metabolites 14 hours after the final exercise bout suggests a prolonged elevation in lipid 
metabolism during the recovery from an intensified endurance training period (Nieman et al., 
2013). Similarly, an acute but prolonged bout of cycling (75 km) caused a 3.1-fold and 1.7-
fold increase in linoleic acid oxidation products 13-HODE and 9-HODE, respectively, and 
showed associations with the onset of oxidative stress as measured by F2-isoprostane levels (r 
= 0.75, p < 0.001, Nieman et al., 2014). This depth of understanding generated from non-
targeted metabolomic analysis supports the subsequent use of 13-HODE and 9-HODE as future 
markers of oxidative stress in response to exercise. The detailed understanding of fatty acid 
  
metabolism during the exercise bout may also help to inform future nutritional strategies that 
target changes in substrate use and/or oxidative stress responses to exercise. 
In addition to products of fatty acid oxidation, induced changes of fatty acid transporter 
molecules have been measured through increases in medium to long-chain acylcarnitines which 
have been demonstrated to increase palmitate oxidation in isolated rat muscle (Krug et al., 
2012; Lehmann et al., 2010; Nieman, Shanely, et al., 2013). Such measurement of circulating 
oxidation products and their transporter molecules could show utility in a medical setting, with 
cardiovascular disease conditions known to display alterations in cardiac tissue metabolism 
through dysregulated substrate utilisation (e.g. Aubert et al., 2016; Bedi et al., 2016); however, 
these current investigations involve exercise interventions that would be too strenuous for 
critically ill patients to perform.  
 The sensitivity of metabolomics to detect changes in fuel use during exercise has been 
demonstrated through observed decreases in serum concentrations of branched-chain amino 
acids in response to repeated 80 m running sprints (Pechlivanis et al., 2013). This is further 
supported by the identification of increased branched-chain amino acid degradation products 
in urine samples after exercise. Furthermore, although changes in the metabolome were 
detected in response to sprint training, there were no observed differences between groups that 
received either a 10 s or 1 min recovery period between sprint intervals (Pechlivanis et al., 
2013). The comprehensive overview of metabolites provided by metabolomic analysis allows 
for greater certainty that the manipulation of recovery periods did not induce metabolic 
differences compared with the measurement of a limited number of variables using a traditional 
approach. More recently, increases in serum lactate, pyruvate, succinate and multiple butyrates, 
along with a reduction in amino acids, has been recorded after a single bout of resistance 
exercise (Berton et al., 2016). Urinary increases in lactate, pyruvate and succinate have also 
been identified as pre- to post-exercise discriminators 30 min after a single 30 s cycle ergometer 
  
sprint (Enea et al., 2010). The use of metabolomics to monitor changes during such high 
intensity exercise may be particularly beneficial as the large anaerobic contribution to energy 
provision prevents accurate interpretation of fuel use from gas exchange measurements (Frayn, 
1983). 
The majority of studies to date have identified biomarkers with known metabolic 
contributions. However, the benefit of a non-targeted metabolomics approach was 
demonstrated by Malkar et al. (2013) through the identification of changes in a salivary 
metabolite of unknown origin in response to exercise. The metabolite was subsequently 
identified as δ-valerolactam, and although this molecule does not have any known 
physiological interactions, the isolation of this compound facilitates further investigation into 
its physiological role as well as the consequences and meaningfulness of the observed changes 
in response to exercise. The previous identification of stress markers such as cortisol has 
benefitted the clinical and scientific interpretation of a variety of stressors including exercise 
(Hough, Corney, Kouris, & Gleeson, 2013). Therefore, although the initial relationship 
between exercise-induced stress and novel biomarkers is merely correlational, subsequent 
identification of the role for such biomarkers may make a significant contribution to future 
research.   
Salivary biomarkers of stress and immune function have been extensively measured 
within sports science settings to minimise the risk of overtraining and upper respiratory tract 
infections in athletes (Meeusen et al., 2013). Although this represents a common approach in 
many sporting environments, this relationship is also largely based on correlational evidence 
and the relationship between markers such as salivary IgA and subsequent infection risk is not 
perfect, with coefficients of determination typically below 30 % (Gleeson et al., 1999; Neville, 
Gleeson, & Folland, 2008). Subsequently, it remains feasible that novel markers of suppressed 
immunity or overtraining may exist which could further assist in the adjustment of training 
  
loads to minimise risk for the athlete. Current evidence supporting the use of non-targeted 
metabolomics to identify novel markers of stress in salivary samples include observed 
elevations in metabolic by-products such as 3-methylhistidine (1.5 fold), glucose phosphate 
isomers (2.5-4.8 fold) and several amino acids (1.2-2.1 fold) in soccer players who expressed 
signs of fatigue after a 3-day program of matches (Ra, Maeda, Higashino, Imai, & Miyakawa, 
2014). A panel of saliva metabolites relevant to cellular energy metabolism (e.g. creatine, 
glucose, lactate, glutamate, acetate) has also been demonstrated to cluster yo-yo test 
performance in football players, suggesting that such measurements may be able to predict 
changes in performance (e.g. performance impairments due to overreaching) which represents 
an avenue for future research (Santone et al., 2014). 
 Aside from investigating changes in the exercise metabolome, researchers have also 
made initial steps into using metabolomics to pinpoint metabolites that may provide insight 
into an individual’s physical capacity, without the need to complete strenuous exercise tests. 
Routine blood tests that could provide predicted values of physical fitness would be of great 
benefit to both the medical and sporting communities, providing physiological monitoring and 
management where a person cannot perform exercise (e.g. critical illness, injury etc.), or where 
avoiding additional physical exertion would be preferred (e.g. an athlete during busy 
competition periods). This approach to using the metabolome as an indicator for health and 
fitness outcomes also aligns with the increasing focus on “precision medicine” (McCarthy, 
2015). In a recent investigation, Lustgarten et al. (2013) reported that pyroxidate, 2-
hydroxybutyrate and 4-vinylphenol sulphate showed significant associations with VO2max in 
both males and females. Furthermore, when these were combined with additional metabolites 
and blood chemistry analytes (e.g. SGOT, blood urea nitrogen), it was possible to explain 58 
and 80% of VO2max scores in males and females, respectively. In another study where 
participants were categorised into high (55 ± 8 mLO2/kg/min) or low (31 ± 7 mLO2/kg/min) 
  
fitness groups, a total of 15 amino acids were reported to be different between the groups in 
both urine and plasma metabolomes (Morris et al., 2013). Further, the authors showed an 
association between leucine and markers linked to metabolic syndrome and insulin resistance, 
suggesting a potential link to changes in amino acid utilisation in unfit individuals that could 
be causative in the development of cardiometabolic disorders. Differences between trained and 
untrained populations for resting levels of amino acid profiles and metabolites related to energy 
production and oxidative stress have also been observed by Yan et al. (2009), thereby providing 
further support for the view that the resting metabolome may reflect physical capacity levels. 
A further study comparing distinct categorised groups of low and high fitness 
demonstrated that the low fitness group had lower levels of phosphatidylcholine and increased 
free choline (approximately 1.5-fold, p = 0.017, Bye et al., 2012). Circulating free choline has 
recently been implicated in cardiovascular disease (Wang et al., 2014) and is known to be 
metabolised by the gut microbiome to form an intermediary in the production of 
trimethylamine N-oxide (Wang et al., 2011), a small molecule metabolite associated with 
reduced survival in conditions such as heart failure and myocardial infarction (Suzuki, Heaney, 
Bhandari, Jones, & Ng, 2016; Suzuki, Heaney, Jones, & Ng, 2016; Tang et al., 2014). Bye and 
colleagues (2012) have provided a basis to further explore exercise training to reduce levels of 
metabolites such as free choline through improving cardiovascular fitness, with the intention 
of reducing the risk of later-life development of cardiometabolic disorders. 
 An additional use of non-targeted strategies in exercise-based investigations has been 
to understand how nutritional interventions interact with the exercise metabolome. Lee and 
colleagues (2010) performed a case study experiment on a participant completing an exhaustive 
submaximal exercise test (75% VO2peak for 45 min followed by 90% VO2peak until fatigue) and 
red blood cell lysates were analysed with a global metabolomics approach. The test was 
completed with and without a high-dose oral intake of N-acetyl-L-cysteine. The results reported 
  
reduced levels of carnitine, acetyl-L-carnitine, creatine and 3-methylhistidine in the 
supplemented trial, with exercise-induced changes in reduced and oxidised glutathione blunted. 
The authors attributed the nutritional supplement as a method to suppress acute exacerbations 
of oxidative stress, although with only one participant the results may not reflect the general 
effect across larger sample sizes. Similarly, studies have shown nutritional interventions to alter 
the circulating levels of molecules related to energy metabolism (Chorell, Moritz, Branth, 
Antti, & Svensson, 2009; Miccheli et al., 2009; Nieman, Gillitt, et al., 2013), with one showing 
that individuals supplemented with a low carbohydrate protein drink and classified into a lower 
fitness group displayed a post-exercise metabolomic profile similar to that of the high fitness 
group who consumed only water (Chorell et al., 2009). Further research is required to fully 
appreciate the influence of nutritional interventions on the metabolome at rest and in 
combination with exercise. The measurement of appropriate outcome variables in response to 
nutritional manipulations that are designed to influence the metabolome may also help to 
substantiate the correlations observed between novel metabolites and parameters of health and 
exercise performance. 
 The implementation of non-targeted metabolomics into sport and exercise science 
investigations is in its early stages and is likely to be increasingly utilised in the coming years. 
The outlined studies present initial exploration and provide a base for future research in the 
field, with many areas of interest yet to be probed.  
  
6. Future implications and potential hurdles 
 Non-hypothesis-driven research into the metabolic changes that occur during sport and 
exercise has recently been termed “Sportomics”. This concept incorporates a top-down study 
model with the analysis of large datasets of metabolic variables collected in response to sports 
training and competition (Bassini & Cameron, 2014). The primary distinction between 
  
Sportomics and the use of metabolomics proposed in the present review is that the Sportomics 
approach typically provides a non-hypothesis driven analysis of a broad range of traditional 
metabolic variables, whereas non-targeted metabolomics monitors a wider range of metabolites 
that may be used to identify novel biomarkers of adaptations to exercise for health and 
performance. We believe that the metabolomics approach discussed in the present review may 
complement and extend the concept of Sportomics. 
In order for novel metabolic biomarkers to be identified for use in exercise and sport, 
non-targeted strategies must be employed. Research questions must be carefully designed so 
that correct collection and analysis of samples is performed, allowing for reliable statistical 
interpretation of the data. Global measurement of metabolites could be applied to help 
understand the athlete’s current state (e.g. fatigue, physical capacity etc.) or for use in aiding 
prediction of future events such as talent identification, onset of illness, susceptibility to injury 
or impaired physical performance.  
Once investigations have been successful in isolating single or multiple metabolites that 
offer beneficial measurements, methods to analyse these must be streamlined in order to allow 
future application with increased throughput (i.e. reduced analysis times) and reduced 
complexity. Methods to achieve these goals come through adaptations to the non-targeted 
analytical workflows that can allow for reduced analysis time and increased sensitivity through 
analyte filtering. Once these targeted strategies have been developed, validation of the 
usefulness of the metabolite screening must be performed and compared to any alternative 
measurements/techniques that are currently available.  
 The major stumbling block for these types of analyses in exercise and sport science is 
the high cost of purchase and maintenance of NMR and MS systems, with trained personnel 
required for the everyday functioning of the instrumentation. However, recent advances in 
technologies have allowed for complex software packages to be simplified and adopt a more 
  
‘plug and play’ style interface, thus increasing the ease of training for non-specialist users. A 
further issue is the space and provision required to operate these forms of instrumentation. 
NMR systems are bulky and extremely heavy due to the housed magnet, and MS systems are 
required to be under a vacuum with a constant supply of electricity and inert gases during 
operation. Efforts are being made to overcome these issues and a recent development in 
portable, compact mass spectrometers (e.g. Heaney et al., 2016) offer a reduced cost and 
footprint that may provide the important steps for the translation from the laboratory to field-
based investigations in exercise and sport. 
 
7. Conclusions 
 Although in its infancy, there is promise for the development of non-targeted 
metabolomic analyses applied to exercise and sport-based scenarios. Non-targeted strategies 
have been employed in the search of new biomarkers for personalised and stratified medicine, 
and present a new direction for the discovery of metabolite indicators for sport and exercise 
science. The coupling of chromatography to MS offers attractive methods for the analysis of 
many hundreds of metabolites in a single analytical run, and can be further developed to employ 
high-throughput, targeted methods for identified metabolites of interest. Moreover, improved 
information of fatigue, physical capacity and performance characteristics through metabolomic 
analyses may be beneficial to sportspeople to achieve their goals with maximum success and 
efficiency, as well as benefiting exercise testing for health and disease investigation.   
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Table Captions 
 
Table 1. A table to show the advantages and limitations of using nuclear magnetic resonance 
spectroscopy (NMR) and mass spectrometry (MS) for non-targeted metabolomics experiments.  
Nuclear magnetic resonance spectroscopy 
Advantages Limitations 
Non-destructive - prepared sample can be stored 
and reanalysed 
Lower sensitivity levels when compared to MS 
High levels of reproducibility Complex samples may exhibit overlapping 
spectral peaks that cannot be deconvoluted 
No requirement for vacuum or gas supply Expensive to purchase and specialised training 
required to operate 
Absolute quantification possible Large housed magnet can be troublesome for 
placement of instrument due to weight and 
interference with surrounding equipment 
Structural information available for measured 
metabolites 
 
  
Mass spectrometry 
Advantages Limitations 
High levels of sensitivity Destructive - injected portion of prepared 
sample cannot be reanalysed 
Ability to measure both intact and fragmented 
ions for improved identification 
Subject to instrument fluctuations across 
experimental periods 
Overlapping chromatographic peaks can be 
deconvoluted by extracting m/z values 
Instruments must remain in vacuum and most 
require access to constant supply of gases (e.g. 
N2, He) 
Highly accurate levels of measured mass 
achievable (e.g. with use of time-of flight and 
orbitrap mass analysers) 
Multiple ionisation states (positive/negative) 
and chromatographic techniques (e.g. reverse 
phase/HILIC) required for full metabolite 
capture 
Increased potential for number of measureable 
analytes from single analysis over NMR 
Constant temperature required to maintain mass 
accuracy (e.g. time-of-flight mass analyser) 
 
Expensive to purchase and specialised training 
required to operate 
 
Metabolite must ionise to be detected and 
potential for competition of ionisation in co-
eluting metabolites 
 
Quantitative data requires presence of an 
internal standard and additional calibration 
curves performed on known standard after 
metabolite identification 
  
  
Figure Captions 
 
 
Figure 1. A generalised workflow for metabolite identification using nuclear magnetic 
resonance spectroscopy (NMR) and mass spectrometry (MS) based technologies for non-
targeted metabolomics experiments. 
*denotes relation to experiments using NMR; ‡ denotes relation to experiments using GC/LC-
MS 
GC = gas chromatography; LC = liquid chromatography; m/z = mass to charge ratio  
  
  
 
Figure 2. Graphical visualisations of plots for a hypothetical non-targeted metabolomics 
experiment in sport and exercise science utilising principle components analysis (PCA; A) and 
orthogonal partial least squares-discriminant analysis (OPLS-DA; B) with its corresponding S-
plot (C). 
A Example PCA plot to show a shift in metabolic profile of participants from pre- (squares) to 
post-exercise (circles), with a tendency to return to pre-exercise characteristics after a period 
of recovery (triangles). Circled stars represent multiple analyses of a quality control (QC) 
sample at regular intervals throughout the analytical period. Close clustering of these indicates 
that low levels of instrumental variation (i.e. good reproducibility) are present across the study. 
B Example OPLS-DA plot to show a supervised multivariate analysis focussed on identifying 
metabolites that exhibit significant differences between pre-defined groups. This plot shows 
differences in metabolite values between pre- (square) and post-exercise (circles) samples. 
C Example corresponding S-plot to visualise the most contributory metabolites to the statistical 
model for separation of pre-defined groups observed from OPLS-DA (Fig 1B). The triangles 
in grey ovals signify the metabolites with the greatest magnitude and reliability of change 
between groups and would commonly be selected for further statistical testing using more 
targeted approaches (e.g. paired t-test, Wilcoxon test, etc.). 
